Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer in Diverse and Low-Resource Settings

PURPOSEGenomic assays are commonly used to predict breast cancer recurrence but remain inaccessible in low-resource settings, often leading to unnecessary chemotherapy. We previously optimized a LASSO-penalized regression model incorporating quantitative clinicopathologic features to predict genomic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rubem Jose Peres Moreira, Jose Bines, Asim Dhungana, Jincong Q. Freeman, Poornima Saha, Megan E. Sullivan, Katharine Yao, Elbio M. Flores, Dezheng Huo, Alexander T. Pearson, Isabele Avila Small, Olufunmilayo I. Olopade, Frederick Matthew Howard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society of Clinical Oncology 2026-05-01
coleção:	JCO Global Oncology
Acesso em linha:	https://ascopubs.org/doi/10.1200/GO-25-00705
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!